UnitedHealth Group Inc. (UNH) Issues FY17 Earnings Guidance
UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY17 earnings guidance on Monday morning. The company provided EPS guidance of $9.30-9.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.11. The company issued revenue guidance of $197-199 billion, compared to the consensus revenue estimate of $196.76 billion.UnitedHealth Group also updated its FY16 guidance to ~$8.00 EPS.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% during trading on Monday, reaching $152.11. 5,022,994 shares of the company traded hands. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50. The stock has a market capitalization of $144.61 billion, a PE ratio of 25.31 and a beta of 0.63. The firm has a 50 day moving average of $143.37 and a 200 day moving average of $139.61.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm had revenue of $46.30 billion for the quarter, compared to the consensus estimate of $46.09 billion. During the same period in the prior year, the firm posted $1.77 earnings per share. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Inc. will post $8.01 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be issued a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.93%.
UNH has been the topic of several recent analyst reports. Jefferies Group reaffirmed a buy rating and set a $163.00 price objective on shares of UnitedHealth Group in a report on Sunday, October 16th. Vetr raised shares of UnitedHealth Group from a buy rating to a buy rating in a report on Friday, October 7th. Evercore ISI initiated coverage on shares of UnitedHealth Group in a report on Thursday, September 22nd. They set a buy rating and a $155.00 price objective on the stock. Cowen and Company set a $150.00 price objective on shares of UnitedHealth Group and gave the company a buy rating in a report on Tuesday, September 6th. Finally, Leerink Swann set a $175.00 price objective on shares of UnitedHealth Group and gave the company a buy rating in a report on Wednesday, October 19th. Two analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company. The company presently has an average rating of Buy and an average price target of $158.03.
In other news, Director Gail R. Wilensky sold 5,460 shares of the business’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the completion of the sale, the director now owns 60,052 shares in the company, valued at approximately $9,040,828.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by corporate insiders.
WARNING: “UnitedHealth Group Inc. (UNH) Issues FY17 Earnings Guidance” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another site, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2016/11/28/unitedhealth-group-inc-unh-issues-fy17-earnings-guidance.html.
Hedge funds have recently modified their holdings of the company. Van Hulzen Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at $104,000. Eubel Brady & Suttman Asset Management Inc. bought a new stake in shares of UnitedHealth Group during the second quarter valued at $209,000. Bellwether Investment Group LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at $220,000. Ancora Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at $238,000. Finally, MCF Advisors LLC increased its stake in shares of UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock valued at $243,000 after buying an additional 763 shares in the last quarter. Institutional investors and hedge funds own 84.92% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.